Cargando…
Corrigendum to “Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care” [EClinicalMedicine 28 (2020) 100,578]
Autores principales: | Fusar-Poli, Paolo, De Micheli, Andrea, Signorini, Lorenzo, Baldwin, Helen, Salazar de Pablo, Gonzalo, McGuire, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868808/ https://www.ncbi.nlm.nih.gov/pubmed/33598646 http://dx.doi.org/10.1016/j.eclinm.2021.100729 |
Ejemplares similares
-
Godspeed, EClinicalMedicine
Publicado: (2018) -
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]”
por: Krolewiecki, Alejandro, et al.
Publicado: (2021) -
Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981]
por: Sun, Yuming, et al.
Publicado: (2023) -
Corrigendum to: Influence of 25‑hydroxy-cholecalciferol levels on SARS-CoV-2 infection and COVID-19 severity: A systematic review and meta-analysis [EClinicalMedicine 37 (2021) 100,967]
por: Crafa, Andrea, et al.
Publicado: (2021) -
Response to the letter by Prof Jonathan Deeks to the Lancet EClinicalMedicine editor
por: Leber, Werner, et al.
Publicado: (2021)